Morphochem AG logo

Morphochem AG

Morphochem is a clinical-stage pharmaceutical company, committed to the development and commercialization of MCB3681, a compound that will provide the basis for an innovative intravenous therapy for severe Clostridium difficile infections.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.morphochem.de
Founded2016
Disease Focus
Development StageClinical
STOCK CODENon Listed
Address
Gmunder Str. 37-37a, 81379
Munich
Germany
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/morphochem-ag” connections=”true” suffix=””]